Analysis of genes involved in drug metabolism and hypersensitivity, allowing clinicians to prescribe with confidence.
Making medicines personal
There are many genes that influence drug metabolism, and since patients may be commonly taking more than one medication, the clinical consequences of genetic variations on drug metabolism can get complex.
Sonic PGx testing involves the identification of clinically important patient genetic variants that affect drug metabolism. Testing can be useful to assess whether a drug will be likely to achieve expected clinical benefit, from identifying individuals who are weak metabolisers. It may predict or explain why some medications work best for individuals where previous drug treatments have not been effective or well-tolerated.
This testing can also help to identify individuals at risk of serious side effects, such as bone marrow suppression or serious cutaneous adverse reactions from certain medications.
Our pharmacogenetic testing service allows us to support clinical medical practice on the quality use of medications and optimal dosing per an individual patient. With genetic awareness, medications can be prescribed to be most effective, as well as safe, for your patient to take.
Medicare reimbursement is generally not available for pharmacogenetic testing, with some exceptions. Results from these complex tests are usually available within two weeks.
Click here to see the test list.
- Sonic PGx example report
- Pharmacogenomics (PGx) information for doctors
- Pharmacogenomics (PGx) test list
- Pharmacogenomics (PGx) request form
- Pharmacogenomics (PGx) technical bulletin - personalise the prescribing of codeine
- Pharmacogenomics (PGx) in mental health - information for doctors
- Pharmacogenomics (PGx) technical bulletin - Pharmacogenomics (PGx) and major depressive disorder
- Technical bulletin - Genetic testing to predict 5-FU/capecitabine toxicity
- Pharmacogenomics (PGx) - tecnical bulletin - genetic testing to predict UGT1A1/Irinotecan
- Technical bulletin - Genetic testing to avoid allopurinol hypersensitivity